Dapagliflozin
Sold as Dapagliflozin cipla, Daglif, Diaxiga, Olfid, Lifloz, Depaflin, Dapagliflozin hetero, Depagloz, Gludapzin, Duforzig, Kedgeo, Tapleo, Dapagliflozin unicorn, Farflozin, Dapiflo, Dapagliflozin ascend, Redifarg, Dapagliflozin sandoz, Dapagliflozin adco, Dapadyn, Dapagliflozin PD, Avaxiga, Dapacaro, Sudapo
(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
Drag to rotate. Structure from PubChem CID 9887712.
Background
Registration
- Applicants
- 15
- Registrations
- 48
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla Medpro (Pty) Ltd | Dapagliflozin cipla | 5, 10 | 530722.72, 530723.721 | S4 | None |
| Zydus Healthcare (Pty) Ltd | Daglif, Diaxiga | 5, 10 | 550049, 550050, 550051.049, 550052.05 | S4 | None |
| Lebasi Pharmaceuticals (Pty) Ltd | Olfid | 5, 10 | 560276, 560277 | S4 | None |
| Abbott Laboratories S.A. (Pty) Ltd | Lifloz | 5, 10 | 560278.276, 560279.277 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Depaflin, Dapagliflozin hetero, Depagloz | 5 mg, 10 mg | 560301, 560302, 560303.301, 560304.302, 560305.301, 560306.302 | S4 | None |
| Austell Pharmaceuticals (Pty) Ltd | Gludapzin | 5, 10 | 560431, 560432 | S4 | None |
| Astrazeneca Pharmaceuticals (Pty) Ltd | Duforzig, Kedgeo, Tapleo | 5, 10 | 560607, 560608, 560609.607, 560610.608, 560611.607, 560612.608 | S4 | PIPIL |
| Unicorn Pharmaceuticals (Pty) Ltd | Dapagliflozin unicorn | 5, 10 | 560673, 560674 | S4 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Farflozin, Dapiflo | 5 mg, 10 mg | 560680, 560681, 560682.680, 560683.681 | S4 | None |
| Ascend Laboratories (Pty) Ltd | Dapagliflozin ascend | 5 mg, 10 mg | 560965, 560966 | S4 | None |
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy's Laboratories (Pty) Ltd. | Redifarg | 5, 10 | 560969, 560970 | S4 | PIPIL |
| Sandoz South Africa (Pty) LtdCertificate held by Sandoz SA Pty Ltd | Dapagliflozin sandoz, Dapacaro, Sudapo | 5, 10 | 570108.106, 580105, 580106, 580107.105, 580109.105, 580110.106 | S4 | PIPIL |
| Adcock ingram limited | Dapagliflozin adco | 5 mg, 10 mg | 570222, 570223 | S4 | PIPIL |
| Pharma Dynamics (Pty) Ltd | Dapadyn, Dapagliflozin PD | 5 mg, 10 mg | 570637, 570638, 570639.567, 570640.638 | S4 | None |
| Innovata pharmaceuticals | Avaxiga | 5, 10 | 570651, 570652 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dapagliflozin cipla 5 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 5,0 mg | 5 | 530722.7253/21.2/0722.720 | Registered | S4 | None |
| Dapagliflozin cipla 10 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg | 10 | 530723.72153/21.2/0723.721 | Registered | S4 | None |
| Daglif 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 55004955/21.2/0049 | Registered | S4 | None |
| Daglif 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 55005055/21.2/0050 | Registered | S4 | None |
| Diaxiga 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 550051.04955/21.2/0051.049 | Registered | S4 | None |
| Diaxiga 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 550052.0555/21.2/0052.050 | Registered | S4 | None |
| Olfid 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 56027656/21.2/0276 | Registered | S4 | None |
| Olfid 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 56027756/21.2/0277 | Registered | S4 | None |
| Lifloz 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 560278.27656/21.2/0278.276 | Registered | S4 | None |
| Lifloz 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 560279.27756/21.2/0279.277 | Registered | S4 | None |
| Depaflin 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 56030156/21.2/0301 | Registered | S4 | None |
| Depaflin 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 56030256/21.2/0302 | Registered | S4 | None |
| Dapagliflozin 5 MG hetero EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 mg | 560303.30156/21.2/0303.301 | Registered | S4 | None |
| Dapagliflozin 10 MG hetero EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 mg | 560304.30256/21.2/0304.302 | Registered | S4 | None |
| Depagloz 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 560305.30156/21.2/0305.301 | Registered | S4 | None |
| Depagloz 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 560306.30256/21.2/0306.302 | Registered | S4 | None |
| Gludapzin 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 56043156/21.2/0431 | Registered | S4 | None |
| Gludapzin 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 56043256/21.2/0432 | Registered | S4 | None |
| Duforzig 5 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 5,0 mg | 5Tablet | 56060756/21.2/0607Approved 12 February 2026 | Registered | S4 | PIPIL |
| Duforzig 10 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg | 10Tablet | 56060856/21.2/0608Approved 12 February 2026 | Registered | S4 | PIPIL |
| Kedgeo 5 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 5,0 mg | 5Tablet | 560609.60756/21.2/0609.607Approved 12 February 2026 | Registered | S4 | PIPIL |
| Kedgeo 10 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg | 10Tablet | 560610.60856/21.2/0610.608Approved 12 February 2026 | Registered | S4 | PIPIL |
| Tapleo 5 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 5,0 mg | 5Tablet | 560611.60756/21.2/0611.607Approved 12 February 2026 | Registered | S4 | PIPIL |
| Tapleo 10 EACH TABLET CONTAINS DAPAGLIFLOZIN PROPRANEDIOL EQUIVALENT TO DAPAGLIFLOZIN 10,0 mg | 10Tablet | 560612.60856/21.2/0612.608Approved 12 February 2026 | Registered | S4 | PIPIL |
| Dapagliflozin 5 unicorn EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 | 56067356/21.2/0673 | Registered | S4 | None |
| Dapagliflozin 10 unicorn EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 | 56067456/21.2/0674 | Registered | S4 | None |
| Farflozin 5 MG EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 mg | 56068056/21.2/0680 | Registered | S4 | None |
| Farflozin 10 MG EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 mg | 56068156/21.2/0681 | Registered | S4 | None |
| Dapiflo 5 MG EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 mg | 560682.68056/21.2/0682.680 | Registered | S4 | None |
| Dapiflo 10 MG EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 mg | 560683.68156/21.2/0683.681 | Registered | S4 | None |
| Dapagliflozin 5 MG ascend EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 mg | 56096556/21.2/0965 | Registered | S4 | None |
| Dapagliflozin 10 MG ascend EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 mg | 56096656/21.2/0966 | Registered | S4 | None |
| Redifarg 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5Tablets | 56096956/21.2/0969Approved 25 September 2024 | Registered | S4 | PIPIL |
| Redifarg 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10Tablets | 56097056/21.2/0970Approved 25 September 2024 | Registered | S4 | PIPIL |
| Dapagliflozin 10 sandoz EACH TABLET CONTAINS: DAPAGLIFLOZIN 10,0 mg | 10Film coated tablets | 570108.10658/21.2/0108.106Approved 27 January 2026 | Registered | S4 | PIPIL |
| Dapagliflozin 5 MG adco EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5 mgFilm-coated tablets | 57022257/21.2/0222Approved 11 March 2025 | Registered | S4 | PIPIL |
| Dapagliflozin 10 MG adco EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10 mgFilm-coated tablets | 57022357/21.2/0223Approved 11 March 2025 | Registered | S4 | PIPIL |
| Dapadyn 5 MG Each Tablet contains: Dapagliflozin Propanediol equivalent to Dapagliflozin 5,0 mg | 5 mg | 57063757/21.2/0637 | Registered | S4 | None |
| Dapadyn 10 MG Each Tablet contains: Dapagliflozin Propanediol equivalent to Dapagliflozin 10,0 mg | 10 mg | 57063857/21.2/0638 | Registered | S4 | None |
| Dapagliflozin 5 MG PD Each Tablet contains: Dapagliflozin Propanediol equivalent to Dapagliflozin 5,0 mg | 5 mg | 570639.56757/21.2/0639.637 | Registered | S4 | None |
| Dapagliflozin 10 MG PD Each Tablet contains: Dapagliflozin Propanediol equivalent to Dapagliflozin 10,0 mg | 10 mg | 570640.63857/21.2/0640.638 | Registered | S4 | None |
| Avaxiga 5 EACH TABLET CONTAINS DAPAGLIFLOZIN 5,0 mg | 5Film-coated tablets | 57065157/21.2/0651Approved 1 October 2024 | Registered | S4 | PIPIL |
| Avaxiga 10 EACH TABLET CONTAINS DAPAGLIFLOZIN 10,0 mg | 10Film-coated tablets | 57065257/21.2/0652Approved 1 October 2024 | Registered | S4 | PIPIL |
| Dapacaro 5 EACH TABLET CONTAINS: DAPAGLIFLOZIN 5,0 mg | 5 | 58010558/21.2/0105 | Registered | S4 | None |
| Dapacaro 10 EACH TABLET CONTAINS: DAPAGLIFLOZIN 10,0 mg | 10 | 58010658/21.2/0106 | Registered | S4 | None |
| Dapagliflozin 5 sandoz EACH TABLET CONTAINS: DAPAGLIFLOZIN 5,0 mg | 5Film coated tablets | 580107.10558/21.2/0107.105Approved 27 January 2026 | Registered | S4 | PIPIL |
| Sudapo 5 EACH TABLET CONTAINS: DAPAGLIFLOZIN 5,0 mg | 5Film coated tablets | 580109.10558/21.2/0109.105Approved 27 January 2026 | Registered | S4 | PIPIL |
| Sudapo 10 EACH TABLET CONTAINS: DAPAGLIFLOZIN 10,0 mg | 10Film coated tablets | 580110.10658/21.2/0110.106Approved 27 January 2026 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Dapagliflozin propranediol equivalent to dapagliflozin
S4: Dapagliflozin
Consolidated Schedules 06 July 2026, line 5942
Pharmacological class: Oral hypoglycaemics. (class 21.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.